Fundraising Fox

Eikon Therapeutics

NASDAQ: EIKN

Hayward, US · Founded 2019 · Delaware corporation · 2 known investors

Biotech

Founders & leadership

RM
Roger M. PerlmutterExecutive Officer, Director
AG
Adam GoulburnDirector
JW
Joshua WolfeDirector
DB
Dror BermanDirector
JT
James TananbaumDirector
LC
Leon ChenDirector
RH
Robbie HuffinesDirector
KF
Kenneth FrazierDirector
RW
Robin WashingtonDirector

Investors · 2

Foresite CapitalLarkspur
Dimension CapitalreportedSan Francisco · $1M – $10M

Reported raises · per SEC filings

Form D private placements
▶$350.7MraisedFeb 2025 · 27 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robbie HuffinesDirector
  • Joshua WolfeDirector
  • Dror BermanDirector
  • James TananbaumDirector
  • Leon ChenDirector
  • Kenneth FrazierDirector
  • Robin WashingtonDirector
  • Roger M. PerlmutterExecutive Officer, Director
Offering amount
$400M
Amount sold
$350.7M
First sale
Feb 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$140.8MraisedJun 2023 · 21 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Robin WashingtonDirector
  • Dan AndersonExecutive Officer
  • Ashish KheterpalExecutive Officer
  • Kenneth FrazierDirector
  • Josh WolfeDirector
  • Dror BermanDirector
  • Russ BermanExecutive Officer
  • Leon ChenDirector
  • James TananbaumDirector
  • Roy BanesExecutive Officer
  • Roger M. PerlmutterExecutive Officer, Director
  • Benjamin ThornerExecutive Officer
  • Alfred BowieExecutive Officer
  • Barbara HowesExecutive Officer
Offering amount
$535M
Amount sold
$140.8M
Minimum investment
$33.7K
First sale
May 2023
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$517.8MraisedJan 2022 · 43 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Alfred BowieExecutive Officer
  • Roger M. PerlmutterExecutive Officer, Director
  • Adam GoulburnDirector
  • James TananbaumDirector
  • Leon ChenDirector
  • Benjamin ThornerExecutive Officer
  • Dror BermanDirector
Offering amount
$525M
Amount sold
$517.8M
First sale
Dec 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$102.5MraisedMay 2021 · 12 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • James TananbaumDirector
  • Leon ChenExecutive Officer, Director
  • Adam GoulburnDirector
  • Roger M PerlmutterExecutive Officer, Director
  • Dror BermanDirector
Offering amount
$107.8M
Amount sold
$102.5M
First sale
May 2021
Incorporated
Corporation, Delaware, 2019
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.